Torpedo Therapeutics

Torpedo Therapeutics is a private, pre-revenue biotech/neurotech company founded in 2020 and based in San Diego. The company is developing a novel DBS platform that integrates microfabricated electrode leads for high-precision stimulation, closed-loop sensing capabilities, and a machine learning-driven data analysis platform for automated therapy adjustment. This approach targets the significant side effects and inefficiencies of current 'always-on' DBS systems. While still in early development, the technology has the potential to improve efficacy, reduce side effects, and decrease the clinical burden for patients with severe neurological disorders.

Integrated neurotechnology platform combining microfabricated electrode leads for high-precision stimulation, closed-loop sensing electronics for real-time neural recording, and a machine learning software platform for automated therapy adjustment.

Competes directly with large incumbent DBS manufacturers (Medtronic, Boston Scientific, Abbott). These companies are iterating on existing platforms with directional leads and limited sensing, but Torpedo's approach is a more fundamental architectural shift. Also competes with other neurotech startups (e.g., Synchron, Paradromics) for talent, funding, and attention in the brain-computer interface space, though with a more focused therapeutic application.